The legacy of Viagra and its creator , copyright, presents a fascinating picture for prospective investors. While the revolutionary drug initially produced enormous profits , its exclusivity has expired , leading to competing alternatives flooding the arena. This decline in cost presents a significant obstacle for copyright and any company consider